Odyssey Group International, Inc. (ODYY)
USD 0.01
(-3.46%)
USD 0.01
(-3.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -2.13 Million USD | 59.67% |
| 2023 | -5.3 Million USD | 32.52% |
| 2022 | -7.6 Million USD | -18.55% |
| 2021 | -6.41 Million USD | -67.23% |
| 2020 | -3.83 Million USD | -1039.12% |
| 2019 | -23.34 Million USD | -20.94% |
| 2018 | -409.89 Thousand USD | -77.33% |
| 2017 | -157.02 Thousand USD | -129.47% |
| 2016 | -68.43 Thousand USD | 56.11% |
| 2015 | -155.89 Thousand USD | -442.27% |
| 2014 | - USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.15 Million USD | -234.12% |
| 2024 Q3 | -372.37 Thousand USD | 36.02% |
| 2024 Q1 | -846.23 Thousand USD | 47.08% |
| 2023 Q1 | -2.07 Million USD | 10.73% |
| 2023 FY | - USD | 32.52% |
| 2023 Q4 | -653.94 Thousand USD | 40.21% |
| 2023 Q3 | -1.09 Million USD | 25.94% |
| 2023 Q2 | -1.47 Million USD | 28.92% |
| 2022 Q3 | -2.86 Million USD | -93.19% |
| 2022 Q1 | -1.42 Million USD | 45.18% |
| 2022 FY | - USD | -18.55% |
| 2022 Q4 | -2.32 Million USD | 18.79% |
| 2022 Q2 | -1.48 Million USD | -3.79% |
| 2021 Q2 | -631.15 Thousand USD | -20.76% |
| 2021 Q1 | -522.63 Thousand USD | -164.25% |
| 2021 Q4 | -2.6 Million USD | 1.77% |
| 2021 FY | - USD | -67.23% |
| 2021 Q3 | -2.65 Million USD | -320.53% |
| 2020 FY | - USD | -1039.12% |
| 2020 Q3 | -1.19 Million USD | -140.74% |
| 2020 Q2 | -497.11 Thousand USD | 62.46% |
| 2020 Q1 | -1.32 Million USD | -741.71% |
| 2020 Q4 | 813.37 Thousand USD | 167.97% |
| 2019 Q1 | -49.76 Thousand USD | 37.12% |
| 2019 Q4 | -157.32 Thousand USD | -269.72% |
| 2019 Q3 | -42.55 Thousand USD | 51.16% |
| 2019 FY | - USD | -20.94% |
| 2019 Q2 | -87.12 Thousand USD | -75.07% |
| 2018 Q1 | -46.85 Thousand USD | -127.46% |
| 2018 Q3 | -54.76 Thousand USD | 43.94% |
| 2018 Q4 | -79.14 Thousand USD | -44.53% |
| 2018 FY | - USD | -77.33% |
| 2018 Q2 | -97.67 Thousand USD | -108.45% |
| 2017 Q2 | -23.39 Thousand USD | 45.94% |
| 2017 FY | - USD | -129.47% |
| 2017 Q4 | -20.6 Thousand USD | 70.47% |
| 2017 Q3 | -69.76 Thousand USD | -198.23% |
| 2017 Q1 | -43.27 Thousand USD | -52.43% |
| 2016 Q4 | -28.38 Thousand USD | -4449.2% |
| 2016 FY | - USD | 56.11% |
| 2016 Q1 | -24.68 Thousand USD | -22339.09% |
| 2016 Q3 | -624.00 USD | 95.77% |
| 2016 Q2 | -14.73 Thousand USD | 40.3% |
| 2015 FY | - USD | -442.27% |
| 2015 Q2 | -1186.00 USD | 65.06% |
| 2015 Q3 | -110.00 USD | 90.73% |
| 2015 Q4 | -110.00 USD | 0.0% |
| 2015 Q1 | -3394.00 USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -679.494% |
| IR-Med Inc. | -4.89 Million USD | 56.294% |
| Polarean Imaging plc | -11.19 Million USD | 80.902% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 568.814% |
| Avitar, Inc. | -1.66 Million USD | -28.197% |
| AVITA Medical, Inc. | -39.56 Million USD | 94.596% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -83.683% |
| Össur hf. | 137.38 Million USD | 101.556% |
| Zecotek Photonics Inc. | -3.44 Million USD | 37.887% |
| QHSLab, Inc. | -91.29 Thousand USD | -2241.991% |
| Wellstar International, Inc. | -1.35 Million USD | -57.615% |
| Össur hf. | 137.38 Million USD | 101.556% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 121.875% |
| Escalon Medical Corp. | -58.46 Thousand USD | -3557.266% |
| Aurora Spine Corporation | -454.37 Thousand USD | -370.55% |
| BrainsWay Ltd. | -2.31 Million USD | 7.483% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 77.204% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 138.722% |
| Vivos Inc. | -2.79 Million USD | 23.453% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.385% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -981.523% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -28.139% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -464.276% |
| Nanomix Corporation | -8.13 Million USD | 73.733% |
| Theraclion SA | -2.05 Million USD | -4.256% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -202.402% |
| Positron Corporation | -1.45 Million USD | -47.235% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -24.171% |
| Lombard Medical, Inc. | -28.06 Million USD | 92.383% |
| ALR Technologies Inc. | -6.4 Million USD | 66.594% |
| Stratec SE | 39.91 Million USD | 105.357% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 2218.1% |
| Heart Tronics, Inc. | -14.85 Million USD | 85.609% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -1707.959% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 83.896% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 76.638% |
| VMS Rehab Systems, Inc. | -68.55 USD | -3118899.271% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 31.604% |
| Ingen Technologies, Inc. | -8639.00 USD | -24649.091% |
| United American Healthcare Corporation | -59 Thousand USD | -3523.854% |
| ECGI Holdings, Inc. | -2.99 Million USD | 28.503% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -239.818% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -315.947% |
| Urologix, Inc. | -6.34 Million USD | 66.298% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -72.514% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -179.134% |
| SS Innovations International, Inc. | -20.37 Million USD | 89.507% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -859.561% |
| Smith & Nephew plc | 1 Billion USD | 100.213% |
| NIOX Group Plc | 11.07 Million USD | 119.305% |
| Fuse Medical, Inc. | 1.83 Million USD | 216.496% |
| Broncus Holding Corporation | -25.19 Million USD | 91.515% |
| Brain Scientific Inc. | -7.93 Million USD | 73.051% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 77.233% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -11519.967% |